Navigation Links
UCSF biochemist wins prestigious prize
Date:12/23/2011

Peter Walter, PhD, a professor in the Biochemistry and Biophysics Department within the School of Medicine at the University of California, San Francisco has been awarded the 2012 Paul Ehrlich and Ludwig Darmstaedter Prize for his "outstanding research achievements in the field of cell biology."

The 100,000 German award specifically recognizes Walter's work over the last two decades on how cells cope with stressinsight that has profound implications for understanding and treating numerous human diseases, including cancer, diabetes, cystic fibrosis and neurodegenerative disorders.

The prize will be awarded in a ceremony in St. Paul's Church in Frankfurt on March 14, the birthday of immunologist Paul Ehrlich (1854-1915), a German scientist who was a towering figure in medicine at the beginning of the 20th century.

"This prize is one of the top international awards given every year for medical research, and it is a wonderful recognition of Dr. Walter's work," said Sam Hawgood, Dean of the UCSF School of Medicine. "His research captures the best this field has to offerfundamental science revealing life's mysteries at its smallest scale and with huge implications for human health worldwide."

Past recipients have included Walter's UCSF colleagues Elizabeth Blackburn, PhD, who won the prize in 2009, and Stanley Prusiner, MD, who won the award in 1995. Both Blackburn and Prusiner also won the Nobel Prize for their work.

Over the last 18 years, Walter and his colleagues have investigated an intracellular process known as the unfolded protein response, which multi-celled organisms use to deal with stress and avoid poisoning their own tissues.

The unfolded protein response regulates the processing of proteins, which all cells produce in great abundance. Some secretory cells in the body make and release the equivalent of their own weight in proteins every single day.

Protein production is tightly controlled, however, to ensure that the body does not poison itself by releasing toxic proteins that are not processed correctly. The unfolded protein response is one of the main ways cells maintain this control.

Basically, explained Walter, "The unfolded protein response makes life and death decisions for the cell."

Those decisions happen in an involuted compartment found within cells known as the endoplasmic reticulum (ER), which can be thought of as a cell's warehouse and way station rolled into one. The vast majority of all the proteins a cell produces are assembled, processed, and packaged there, and the ER ensures that proteins are folded correctly into their final shape and that no misfolded, and potentially malfunctioning and toxic, proteins are released into surrounding tissues.

The ER warehouse can become overworked and too crowded at times, putting stress on cells. When stressed, cells can exercise a sort of nuclear option, switching on a program known as apoptosis and killing themselves. The unfolded protein response is a fail-safe switch in this mechanism. It can pull a cell back from the edge by making more ER, expanding capacity for more proteins to fold properly, thereby relieving the stress.

A few years ago Walter discovered the lynchpin in the process, a protein known as IRE1. This protein is a molecular detector in the ER that gauges when things become too crowded and triggers cell changesthat expand ER space.

This process can also go awry, and when it does, it can lead to a number of different diseases, including cancer. In multiple myeloma, for instance, IRE1 appears to go haywire and the cancer cells "forget how to die," as Walter described it.

Blocking the IRE1 protein with small molecules may help people with this form of cancer, he saida therapeutic possibility that Walter and his colleagues are actively pursuing.

"The Paul Ehrlich and Ludwig Darmstaedter Prize is particularly special to all of us in the Department of Biochemistry and Biophysics at UCSF because it is an award in the field of medicine that has been conferred upon one of our celebrated basic scientists," said Graeme Davis, PhD, Albert Bowers Professor at UCSF and Chair of the Department of Biochemistry & Biophysics.

"Tackling fundamental questions with direct relevance to human health is something that we all aspire to," Davis added.


'/>"/>

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

Related biology news :

1. UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants
2. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
3. Biochemistry of human physiology in health and disease is focus of updated clinical text
4. Phytoplankton cell membranes challenge fundamentals of biochemistry
5. UC Riverside biochemist to study how crops can increase protein production
6. ASBMB Annual Meeting to feature talks on the biochemistry of aging
7. Springer partners with the American Society for Biochemistry and Molecular Biology
8. Stimulus funding helps K-State biochemist study eyes lens in diabetes, galactosemia patients
9. Biochemist researching computer models of protein structure that help high school, college students
10. Biochemist unlocks genes role in breast-tumor growth
11. Colorado State University biochemists study how chromosomes unravel to let genes do their jobs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF biochemist wins prestigious prize
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: